NEW YORK – After having risen 4 percent in April, the GenomeWeb Index turned back down in May, losing nearly 4 percent.
The index underperformed the Dow Jones Industrial Average, the Nasdaq, and the Nasdaq Biotechnology Index, which rose more than 1 percent, fell more than 2 percent, and fell 2 percent, respectively, in May. Performance of individual stocks in the GenomeWeb Index was largely negative last month, as 23 of the 36 stocks saw losses and 13 saw gains.
Fluidigm led the gainers in May with a 16 percent increase in share price, followed by Quidel (+13 percent) and PerkinElmer (+12 percent). Quidel had placed second on the list of decliners in April with a 20 percent loss in share price.
NanoString Technologies led the decliners in May with a 30 percent drop in stock price, followed by Guardant Health and Veracyte with a loss of 22 percent each. NanoString had led the list of gainers in April with a 21 percent increase in share price.